Alcon AG
SIX:ALC

Watchlist Manager
Alcon AG Logo
Alcon AG
SIX:ALC
Watchlist
Price: 78.52 CHF 1.19% Market Closed
Market Cap: 39.2B CHF
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one ALC stock under the Base Case scenario is hidden CHF. Compared to the current market price of 78.52 CHF, Alcon AG is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALC Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

4.7
P/S
P/S
Price to Sales
4.7
vs History
22
vs Industry
27
Median 3Y
4.3
Median 5Y
4.5
Industry
2.2
Forward
4.5
More Details
46.1
P/E
P/E
Price to Earnings
46.1
vs History
47
vs Industry
11
Median 3Y
60
Median 5Y
45.2
Industry
21.8
Forward
28.5
More Details
22.6
P/OCF
P/OCF
Price to OCF
22.6
vs History
88
vs Industry
16
Median 3Y
27.2
Median 5Y
28.3
Industry
13.4
More Details
41.8
P/FCFE
P/FCFE
Price to FCFE
41.8
vs History
68
vs Industry
9
Median 3Y
52.7
Median 5Y
51
Industry
19
More Details
2.2
P/B
P/B
Price to Book Value
2.2
vs History
7
vs Industry
39
Median 3Y
2
Median 5Y
1.9
Industry
2.1
More Details
5.1
EV/S
EV/S
Enterprise Value to Sales
5.1
vs History
33
vs Industry
24
Median 3Y
4.7
Median 5Y
4.8
Industry
2.3
Forward
4.8
More Details
9.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.1
vs History
46
vs Industry
24
Median 3Y
8.6
Median 5Y
8.9
Industry
4.8
More Details
19.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
19.4
vs History
49
vs Industry
18
Median 3Y
18.9
Median 5Y
19.1
Industry
11.4
Forward
17.4
More Details
37
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
37
vs History
65
vs Industry
12
Median 3Y
38.9
Median 5Y
40
Industry
15.5
Forward
23.4
More Details
24.1
EV/OCF
EV/OCF
Enterprise Value to OCF
24.1
vs History
90
vs Industry
16
Median 3Y
29.8
Median 5Y
31.4
Industry
13.3
More Details
35.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
35.6
vs History
69
vs Industry
12
Median 3Y
43.1
Median 5Y
78.4
Industry
17.1
More Details
1.8
EV/IC
EV/IC
Enterprise Value to IC
1.8
vs History
7
vs Industry
41
Median 3Y
1.6
Median 5Y
1.5
Industry
1.8
More Details

Multiples Across Competitors

ALC Competitors Multiples
Alcon AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CH
Alcon AG
SIX:ALC
38.8B CHF 4.7 46.1 19.4 37
JP
Hoya Corp
TSE:7741
5.7T JPY 6.8 27.6 18.2 21.8
DK
Coloplast A/S
CSE:COLO B
163.4B DKK 6 33.5 20.7 24.4
US
Align Technology Inc
NASDAQ:ALGN
13.5B USD 3.4 32.1 15.3 18.6
UK
ConvaTec Group PLC
LSE:CTEC
5.3B GBP 3.1 36.8 208.6 341.2
US
Lantheus Holdings Inc
NASDAQ:LNTH
7B USD 4.5 22.3 12.9 14.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
41.3B CNY 9.3 22.3 19.2 19.2
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.6B USD 4.1 46.2 21.2 36
CH
Ypsomed Holding AG
SIX:YPSN
4.7B CHF 7.6 62.7 30.3 56.8
KR
HLB Inc
KOSDAQ:028300
7.2T KRW 106.3 -78.7 -63.9 -60.5
CA
Bausch + Lomb Corp
NYSE:BLCO
4.8B USD 1 -15.3 14.5 45
P/E Multiple
Earnings Growth PEG
CH
Alcon AG
SIX:ALC
Average P/E: 36.6
46.1
28%
1.6
JP
Hoya Corp
TSE:7741
27.6
14%
2
DK
Coloplast A/S
CSE:COLO B
33.5
14%
2.4
US
Align Technology Inc
NASDAQ:ALGN
32.1
30%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
36.8
33%
1.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
22.3
27%
0.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
22.3
20%
1.1
US
Merit Medical Systems Inc
NASDAQ:MMSI
46.2
30%
1.5
CH
Ypsomed Holding AG
SIX:YPSN
62.7
40%
1.6
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -78.7 N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -15.3 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CH
Alcon AG
SIX:ALC
Average EV/EBITDA: 38
19.4
11%
1.8
JP
Hoya Corp
TSE:7741
18.2
14%
1.3
DK
Coloplast A/S
CSE:COLO B
20.7
11%
1.9
US
Align Technology Inc
NASDAQ:ALGN
15.3
16%
1
UK
ConvaTec Group PLC
LSE:CTEC
208.6
10%
20.9
US
Lantheus Holdings Inc
NASDAQ:LNTH
12.9
23%
0.6
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
19.2
26%
0.7
US
Merit Medical Systems Inc
NASDAQ:MMSI
21.2
14%
1.5
CH
Ypsomed Holding AG
SIX:YPSN
30.3
31%
1
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -63.9 N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
14.5
21%
0.7

See Also

Summary
ALC intrinsic value, competitors valuation, and company profile.
DCF Valuation
ALC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ALC stock valuation using valuation multiples.
Wall Street Estimates
ALC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ALC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 249,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.